Application 219386
- Type
- ANDA
- Sponsor
- HETERO LABS LTD UNIT III
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUVOREXANT | SUVOREXANT | TABLET | 5MG | No | No |
| 002 | SUVOREXANT | SUVOREXANT | TABLET | 10MG | No | No |
| 003 | SUVOREXANT | SUVOREXANT | TABLET | 15MG | No | No |
| 004 | SUVOREXANT | SUVOREXANT | TABLET | 20MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BELSOMRA | SUVOREXANT | Merck Sharp & Dohme LLC | e5b72731-1acb-45b7-9c13-290ad12d3951 | 2025-03-10 | Warnings, Adverse reactions | SUVOREXANT |